Clinical characteristics and survival of patients with an adult-type ovarian granulosa cell tumor a 56-year single-center experience

International Journal of Gynecological Cancer

Volumn 25, Issue 1, 2015, Pages 33-41

  Bryk, Saara ^a   Färkkilä, Anniina ^a   Bützow, Ralf ^a   Leminen, Arto ^a   Heikinheimo, Markku ^a,b   Anttonen, Mikko ^a   Riska, Annika ^a   Unkila Kallio, Leila ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Granulosa cell tumor; Ovarian cancer; Prognostic factors; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; FOLLOW UP; GRANULOSA CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; TUMOR VOLUME; ADOLESCENT; AGED; CLINICAL TRIAL; LYMPH NODE DISSECTION; MIDDLE AGED; MORTALITY; NEOPLASM, RESIDUAL; PATHOLOGY; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GRANULOSA CELL TUMOR; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84927732323     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000304     Document Type: Article

References (23)

1. Malmstrom H, Hogberg T, Risberg B, et al. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol. 1994;52:50-55.
2. Lee IH, Choi CH, Hong DG, et al. Clinicopathologic characteristics of granulosa cell tumors of the ovary: Amulticenter retrospective study. J Gynecol Oncol. 2011;22: 188-195.
3. Fox H, Agrawal K, Langley FA. A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis. Cancer. 1975;35:231-241.
4. Unkila-Kallio L, Tiitinen A, Wahlstrom T, et al. Reproductive features in women developing ovarian granulosa cell tumour at a fertile age. Hum Reprod. 2000;15:589-593.
5. Evans A, Gaffey T, Malkasian G, et al. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol. 1980;55:231-248.
6. Ayhan A, Salman MC, Velipasaoglu M, et al. Prognostic factors in adult granulosa cell tumors of the ovary: A retrospective analysis of 80 cases. J Gynecol Oncol. 2009;20:158-163.
7. Cronje HS, Niemand I, Bam RH, et al. Review of the granulosa-theca cell tumors from the Emil Novak ovarian tumor registry. Am J Obstet Gynecol. 1999;180:323-327.
8. Park JY, Jin KL, Kim DY, et al. Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol. 2012;125:80-86.
9. Homesley HD, Bundy BN, Hurteau JA, et al. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study. Gynecol Oncol. 1999;72:131-137.
10. Pautier P, Gutierrez-Bonnaire M, Rey A, et al. Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer. 2008;18:446-452.
11. Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol. 1981;11:261-274.
12. Mangili G, Ottolina J, Gadducci A, et al. Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. Br J Cancer. 2013;109:29-34.
13. Sun HD, Lin H, Jao MS, et al. A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol. 2012;124:244-249.
14. Ohel G, Kaneti H, Schenker JG. Granulosa cell tumors in Israel: A study of 172 cases. Gynecol Oncol. 1983;15: 278-286.
15. Miller BE, Barron BA, Wan JY, et al. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer. 1997;79: 1951-1955.
16. Norris HJ, Taylor HB. Prognosis of granulosa-theca tumors of the ovary. Cancer. 1968;21:255-263.
17. FIGO Committee on Gynecologic Oncology. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet. 2009;105:3-4.
18. Kommoss S, Gilks CB, Penzel R, et al. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Histopathology. 2014;64:380-388.
19. Boyce EA, Costaggini I, Vitonis A, et al. The epidemiology of ovarian granulosa cell tumors: A case-control study. Gynecol Oncol. 2009;115:221-225.
20. Rantala ML, Koskimies AI. Infertility in women participating in a screening program for cervical cancer in Helsinki. Acta Obstet Gynecol Scand. 1986;65:823-825.
21. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr. 2005;147:753-760.
22. Farkkila A, Andersson N, Bützow R, et al. HER2 and GATA4 are new prognostic factors for ovarian granulosa cell tumor: A long-term follow-up study. Cancer Med. 2014;3:526-536.
23. Savage P, Constenla D, Fisher C, et al. Granulosa cell tumours of the ovary- Demographics, survival and the management of advanced disease. Clin Oncol (R Coll Radiol). 1998;10: 242-245.